Type of menopause, age of menopause and cardiovascular disease: a cross-sectional study based on data from Rafsanjan cohort study
- PMID: 39593060
- PMCID: PMC11590513
- DOI: 10.1186/s12905-024-03452-x
Type of menopause, age of menopause and cardiovascular disease: a cross-sectional study based on data from Rafsanjan cohort study
Abstract
Background: Cardiovascular disease is the leading cause of death among women, but sex-specific risk factors are incompletely understood. In this study, we aimed to assess the associations between the type of menopause, and age at natural menopause with the odds of cardiovascular disease (CVD), and coronary heart disease (CHD).
Methods: This cross-sectional study is a part of data from the Rafsanjan Cohort Study (RCS) which is a branch of the Prospective Epidemiological Research Studies in Iran (PERSIAN). A sample of 1767 postmenopausal women were included. The diagnosis for CVD and CHD was based on self-report questionnaires. Menopause age was categorized as < 40, 40-44, 45-49, and ≥ 50. Also, the menopause types were classified as natural and induced menopause (surgery or chemotherapy). The association was evaluated by logistic regressions.
Results: The menopause age < 40 years had higher odds of CVD compared to women with menopause age > 40 years (OR: 2.66; 95%CI 1.29-5.48). Women with induced menopause had higher odds of CVD compared to women with natural menopause (OR = 1.44, 95% CI 1.04-1.98). In terms of the odds of CHD, the results showed that the odds of CHD increased in menopause age < 40 years and induced menopause compared to reference groups (OR: 2.49, 95% CI 1.15-5.37, OR = 1.48; 95% CI 1.06-2.07, respectively).
Conclusion: Premature menopause and induced menopause should be considered as important risk factors for CVD, and CHD. Health policymakers should pay more attention to the type of menopause and the age of menopause in postmenopausal women to predict the risk of CVD and preventive strategies.
Keywords: Cardiovascular diseases; Coronary disease; Early menopause; Menopause; Premature menopause; Prospective epidemiological research studies in Iran (PERSIAN); Rafsanjan cohort study (RCS).
© 2024. The Author(s).
Conflict of interest statement
Declarations. Ethical approval: The study protocol was approved by the ethics committee of Rafsanjan University of Medical Sciences (Ethical codes: ID: IR.RUMS.REC.1400.145). Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
References
-
- Wilkins E, Wilson L, Wickramasinghe K, Bhatnagar P. European Heart Network. European Cardiovascular Disease statistics 2017. In.: Brussels: European Heart Network.
-
- Maas AH, Rosano G, Cifkova R, Chieffo A, van Dijken D, Hamoda H, Kunadian V, Laan E, Lambrinoudaki I, Maclaran K. Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists. Eur Heart J. 2021;42(10):967–84. - PMC - PubMed
-
- Stevenson J, Collins P, Hamoda H, Lambrinoudaki I, Maas A, Maclaran K, Panay N. Cardiometabolic health in premature ovarian insufficiency. Climacteric. 2021;24(5):474–80. - PubMed
-
- Zhu D, Chung H-F, Pandeya N, Dobson AJ, Kuh D, Crawford SL, Gold EB, Avis NE, Giles GG, Bruinsma F. Body mass index and age at natural menopause: an international pooled analysis of 11 prospective studies. Eur J Epidemiol. 2018;33:699–710. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
